Vertically integrated cannabis company Ayr Wellness Inc. (CSE:AYR) (OTCQX:AYRWF) reported Wednesday that its revenue spiked 74% year-over-year, reaching $58.4 million in the first quarter of 2021, beating the consensus sales estimates. The Analyst Cantor Fitzgerald's analyst Pablo Zuanic reaffirmed their "Neutral" rating on Ayr's stock, trimming their 12-month price target to $33.5 from $36. Over the quarter, the Toronto-based company wrapped up the acquisition of Liberty Health Sciences, adding 42 Florida-based stores to its portfolio. In addition, it purchased Arizona-based Blue Camo LLC, which operates as Oasis, and its three medical and adult-use dispensaries in the greater Phoenix area. Ayr also bought a triple-stacked cultivation and processing facility in Chandler, which spans 10,000 square feet, as well as 86,000 square feet of cultivation property in Phoenix, which is still under development.